{"document_type": "article", "byline": {"contributor": "", "person": [{"role": "reported", "firstname": "Eric", "organization": "", "rank": 1, "lastname": "LIPTON"}, {"role": "reported", "firstname": "Rachel", "organization": "", "rank": 2, "lastname": "ABRAMS"}], "original": "By ERIC LIPTON and RACHEL ABRAMS"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-thumbWide.jpg", "legacy": {"wide": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "391"}, "width": 600, "subtype": "xlarge", "height": 391}, {"type": "image", "url": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "Tactic by Maker of EpiPen Could Quell Protests", "main": "EpiPen Maker Lobbies to Shift High Costs to Others"}, "print_page": "1", "keywords": [{"value": "Mylan Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Epinephrine (Drug)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Lobbying and Lobbyists", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Law and Legislation", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "Y", "rank": "6", "name": "subject"}, {"value": "United States Preventive Services Task Force", "is_major": "N", "rank": "7", "name": "organizations"}], "snippet": "Inclusion on a federal list would mean Mylan could keep its list price high \u2014 or even raise it \u2014 without patients\u2019 complaining. But consumers would feel it indirectly....", "source": "The New York Times", "lead_paragraph": "Inclusion on a federal list would mean Mylan could keep its list price high \u2014 or even raise it \u2014 without patients\u2019 complaining. But consumers would feel it indirectly.", "word_count": "2082", "pub_date": "2016-09-16T07:30:34+0000", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/09/16/business/epipen-maker-mylan-preventative-drug-campaign.html", "_id": "57db9f9f95d0e021d7986943"}